Cargando…

Idiopathic Pulmonary Fibrosis and Telomeres

Idiopathic pulmonary fibrosis is an interstitial lung disease of unknown etiology with a highly compromised prognosis and a significant mortality rate within a few years of diagnosis. Despite being idiopathic, it has been shown that telomeric shortening could play an important role in its etiopathog...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulet, Alba, Signes-Costa, Jaime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740997/
https://www.ncbi.nlm.nih.gov/pubmed/36498467
http://dx.doi.org/10.3390/jcm11236893
_version_ 1784848207009808384
author Mulet, Alba
Signes-Costa, Jaime
author_facet Mulet, Alba
Signes-Costa, Jaime
author_sort Mulet, Alba
collection PubMed
description Idiopathic pulmonary fibrosis is an interstitial lung disease of unknown etiology with a highly compromised prognosis and a significant mortality rate within a few years of diagnosis. Despite being idiopathic, it has been shown that telomeric shortening could play an important role in its etiopathogenesis. Mutations in telomere-related genes have been identified, but they are not always present despite telomere shortening. On the other hand, this telomeric shortening has been linked to a worse prognosis of the disease independently of other clinical factors, implying it may serve as a biomarker.
format Online
Article
Text
id pubmed-9740997
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97409972022-12-11 Idiopathic Pulmonary Fibrosis and Telomeres Mulet, Alba Signes-Costa, Jaime J Clin Med Review Idiopathic pulmonary fibrosis is an interstitial lung disease of unknown etiology with a highly compromised prognosis and a significant mortality rate within a few years of diagnosis. Despite being idiopathic, it has been shown that telomeric shortening could play an important role in its etiopathogenesis. Mutations in telomere-related genes have been identified, but they are not always present despite telomere shortening. On the other hand, this telomeric shortening has been linked to a worse prognosis of the disease independently of other clinical factors, implying it may serve as a biomarker. MDPI 2022-11-22 /pmc/articles/PMC9740997/ /pubmed/36498467 http://dx.doi.org/10.3390/jcm11236893 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Mulet, Alba
Signes-Costa, Jaime
Idiopathic Pulmonary Fibrosis and Telomeres
title Idiopathic Pulmonary Fibrosis and Telomeres
title_full Idiopathic Pulmonary Fibrosis and Telomeres
title_fullStr Idiopathic Pulmonary Fibrosis and Telomeres
title_full_unstemmed Idiopathic Pulmonary Fibrosis and Telomeres
title_short Idiopathic Pulmonary Fibrosis and Telomeres
title_sort idiopathic pulmonary fibrosis and telomeres
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740997/
https://www.ncbi.nlm.nih.gov/pubmed/36498467
http://dx.doi.org/10.3390/jcm11236893
work_keys_str_mv AT muletalba idiopathicpulmonaryfibrosisandtelomeres
AT signescostajaime idiopathicpulmonaryfibrosisandtelomeres